Metoclopramide. An updated review of its pharmacological properties and clinical use
- PMID: 6345129
- DOI: 10.2165/00003495-198325050-00002
Metoclopramide. An updated review of its pharmacological properties and clinical use
Abstract
Since previously reviewed in the Journal (Vol. 12, No. 2), metoclopramide has been confirmed as an effective drug in treating and preventing various types of vomiting and as a useful agent in oesophageal reflux disease, gastroparesis, dyspepsia, and in a variety of functional gastrointestinal disorders. Of considerable importance is the recent evidence of its efficacy when administered intravenously in high dosages in preventing severe vomiting associated with cisplatin. Good results have been achieved in patients not previously treated with cisplatin, but further studies are needed to determine its level of efficacy in patients who have experienced severe vomiting during earlier courses of cytotoxic therapy. Side effects consisting of mild sedation, diarrhoea and reversible extrapyramidal reactions have occurred, but are tolerated by many patients.
Similar articles
-
Metoclopramide: a review of its pharmacological properties and clinical use.Drugs. 1976;12(2):81-131. doi: 10.2165/00003495-197612020-00001. Drugs. 1976. PMID: 786607 Review.
-
Review of a new gastrointestinal drug--metoclopramide.Am J Hosp Pharm. 1981 Jun;38(6):829-33. Am J Hosp Pharm. 1981. PMID: 7018232 Review.
-
Metoclopramide. A review of antiemetic trials.Drugs. 1983 Feb;25 Suppl 1:63-73. doi: 10.2165/00003495-198300251-00007. Drugs. 1983. PMID: 6682376
-
Drug therapy. Metoclopramide.N Engl J Med. 1981 Jul 2;305(1):28-33. doi: 10.1056/NEJM198107023050106. N Engl J Med. 1981. PMID: 7015140 Review. No abstract available.
-
Metoclopramide--a review.Med J Aust. 1986 Mar 31;144(7):366-9. doi: 10.5694/j.1326-5377.1986.tb115923.x. Med J Aust. 1986. PMID: 3515136 Review.
Cited by
-
Antagonism of cisplatin-induced emesis by metoclopramide and dazopride through enhancement of gastric motility.Dig Dis Sci. 1986 May;31(5):524-9. doi: 10.1007/BF01320319. Dig Dis Sci. 1986. PMID: 3698769
-
The detoxification limitation hypothesis: where did it come from and where is it going?J Chem Ecol. 2006 Jun;32(6):1247-66. doi: 10.1007/s10886-006-9082-3. Epub 2006 May 23. J Chem Ecol. 2006. PMID: 16770716 Review.
-
Stimulation of aldosterone secretion by metoclopramide is not affected by chronic converting enzyme inhibition.Eur J Clin Pharmacol. 1985;29(2):207-10. doi: 10.1007/BF00547423. Eur J Clin Pharmacol. 1985. PMID: 3000795
-
Birth outcome following maternal use of metoclopramide. The Euromap study group.Br J Clin Pharmacol. 2000 Mar;49(3):264-8. doi: 10.1046/j.1365-2125.2000.00127.x. Br J Clin Pharmacol. 2000. PMID: 10718782 Free PMC article.
-
Mechanism of action for N-substituted benzamide-induced apoptosis.Br J Cancer. 2002 Mar 18;86(6):971-8. doi: 10.1038/sj.bjc.6600136. Br J Cancer. 2002. PMID: 11953831 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources